Literature DB >> 16227623

Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth.

Mariana I Capurro1, Wen Shi, Shaifali Sandal, Jorge Filmus.   

Abstract

Glypicans are a family of heparan sulfate proteoglycans that are bound to the cell surface by a lipid anchor. Six members of this family have been identified in mammals (GPC1-GPC6). Glypicans act as regulators of the activity of various cytokines, including Wnts, Hedgehogs, and bone morphogenetic proteins. It has been reported that processing by a convertase is required for GPC3 activity during convergent extension in zebrafish embryos, for GPC3-induced regulation of Wnt signaling, and for the binding of GPC3 to Wnt5a. In our laboratory, we have recently demonstrated that GPC3 promotes the growth of hepatocellular carcinomas (HCCs) by stimulating canonical Wnt signaling. Because there is increasing evidence indicating that the structural requirements for GPC3 activity are cell type specific, we decided to investigate whether GPC3 needs to be processed by convertases to stimulate cell proliferation and Wnt signaling in HCC cells. We report here that a mutant GPC3 that cannot be processed by convertases is still able to play its stimulatory role in Wnt activity and HCC growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227623     DOI: 10.1074/jbc.M507004200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation.

Authors:  Jin-Ping Lai; Abdul M Oseini; Catherine D Moser; Chunrong Yu; Sherine F Elsawa; Chunling Hu; Ikuo Nakamura; Tao Han; Ileana Aderca; Hajime Isomoto; Megan M Garrity-Park; Abdirashid M Shire; Jia Li; Schuyler O Sanderson; Alex A Adjei; Martin E Fernandez-Zapico; Lewis R Roberts
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

2.  Glypican-3 as an emerging molecular target for hepatocellular carcinoma gene therapy.

Authors:  Min Yao; Li Wang; Zhizhen Dong; Qi Qian; Yun Shi; Dandan Yu; Shiye Wang; Wenjie Zheng; Dengfu Yao
Journal:  Tumour Biol       Date:  2014-03-16

Review 3.  Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.

Authors:  Mitchell Ho
Journal:  BioDrugs       Date:  2011-10-01       Impact factor: 5.807

4.  Structural remodeling of proteoglycans upon retinoic acid-induced differentiation of NCCIT cells.

Authors:  Leyla Gasimli; Hope E Stansfield; Alison V Nairn; Haiying Liu; Janet L Paluh; Bo Yang; Jonathan S Dordick; Kelley W Moremen; Robert J Linhardt
Journal:  Glycoconj J       Date:  2012-10-02       Impact factor: 2.916

5.  Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.

Authors:  Youcai Li; Jun Zhang; Jiamei Gu; Kongzhen Hu; Shun Huang; Peter S Conti; Hubing Wu; Kai Chen
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

6.  Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro.

Authors:  Mingqian Feng; Heungnam Kim; Yen Phung; Mitchell Ho
Journal:  Int J Cancer       Date:  2011-05-01       Impact factor: 7.396

7.  Structure of the protein core of the glypican Dally-like and localization of a region important for hedgehog signaling.

Authors:  Min-Sung Kim; Adam M Saunders; Brent Y Hamaoka; Philip A Beachy; Daniel J Leahy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-26       Impact factor: 11.205

8.  Integration of left-right Pitx2 transcription and Wnt signaling drives asymmetric gut morphogenesis via Daam2.

Authors:  Ian C Welsh; Michael Thomsen; David W Gludish; Catalina Alfonso-Parra; Yan Bai; James F Martin; Natasza A Kurpios
Journal:  Dev Cell       Date:  2013-09-30       Impact factor: 12.270

Review 9.  Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans.

Authors:  Catherine Kirn-Safran; Mary C Farach-Carson; Daniel D Carson
Journal:  Cell Mol Life Sci       Date:  2009-07-24       Impact factor: 9.261

Review 10.  Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.

Authors:  Jin-Ping Lai; James R Thompson; Dalbir S Sandhu; Lewis R Roberts
Journal:  Future Oncol       Date:  2008-12       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.